top of page

François Moreau, Scientific Director

Mutabilis, France

Mutabilis has started a very high quality collaboration with Ilonka already in 2012, during which she took care of our mature programs from IND-enabling studies up to Phase I as project manager with a specific emphasis on toxicology studies. She works for us as if she were an employee of Mutabilis, designing ad hoc studies, selecting the appropriate CROs for their execution and managing them daily up to regulatory documents writing and IND, with a really impressive ability to communicate with all actors clearly, openly, always in a timely manner and with a strong problem-solving capacity.

She is a very positive and dynamic person, flexible and always planning for success. Ilonka has an excellent knowledge of, and experience in toxicology both on scientific and regulatory aspects. She also has a very good picture of the whole non-clinical process and requirements covering Drug Substance / Drug Product characterization, bioanalysis and toxicokinetics. Thus, NonClinical Insights provides a really well-suited service for small biopharmaceutical companies with products approaching preclinical studies.

Céline Gerard,

Non-Clinical Project Leader

Mithra Pharmaceuticals, France

We had the pleasure to collaborate with Nonclinical Insights on a number of projects in different fields, for which responsiveness and immediate reactivity were often required. This collaboration was extremely valuable. We have always been satisfied by the quality of the feedbacks and documents delivered. Ilonka is responsive, flexible, and rigorous and easily understands needs and requirements. Her help truly facilitated the set-up of an important nonclinical study in a timely manner. We have been completely satisfied with Nonclinical Insights and we have no hesitation in recommending their expertise.

Johan te Koppele,

Former Line Manager

Venn Life Sciences,

The Netherlands

I had the pleasure to work with Ilonka for 8 years. Ilonka executed the role team leader/director Non-Clinical Development in an excellent way: she was leader as well as supporter of her team, she was very knowledgeable in the non-clinical safety of drugs, and her contribution to the Management Team was valuable. Clients love to work with Ilonka. On the one hand because of her knowledge. On the other hand since she is a very pleasant person to work with. A nice balance between soft and hard skills. I strongly recommend Ilonka.

Dr. Julien Beyrath, CSO


The Netherlands

Ilonka has flawlessly supported us, and still is, with the non-clinical development of our lead candidate now entering late clinical phase. Ilonka is very knowledgeable, efficient in preparing and executing actionable plans and is well connected to all expertises needed. For me to write a client testimonial simply showcases the positive, professional and pleasant relationship we've had with Ilonka since 2014.

bottom of page